Precision IO Group Inc. — SEC Form D Filing

Precision IO Group Inc. filed an SEC Form D on October 16, 2026, reporting $8.54M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
October 16, 2026
Amount reported
$8.54M
Round stage
Series B+
Industry
Medical Devices
Website
https://precisionio.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

There is a need to improve outcomes for cancer patients by enhancing the precision and accessibility of minimally invasive cancer treatments like tumor ablation and interventional oncology procedures.

Solution

Precision IO Group develops robotic-assisted and microwave ablation systems that integrate robotics and AI to deliver precise, image-guided, minimally invasive tumor ablation and interventional oncology procedures, also enabling remote procedures.

Why now

Advancements in robotics, AI, and medical imaging now allow for highly precise, image-guided minimally invasive cancer treatments, which were previously less feasible or accurate.

Verdict

Investors cleared this round because the narrative positioned robotic-assisted, AI-guided ablation as a definitive leap in treatment precision and accessibility for cancer care, not simply an incremental improvement to existing interventional oncology tools. The implicit bet was on a paradigm shift in procedural efficacy and throughput, where superior targeting and remote capabilities could significantly expand the addressable patient population or procedure volume. Upside was constrained by the long sales cycles and regulatory hurdles inherent in replacing established, if less optimal, medical device workflows.

Source: SEC EDGAR Form D filing